🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the tolerability and safety of Xev...
Status
Terminated
Location
Mount Sinai Comprehensive Cancer Center
Start Date
2024-01-18
Trial ID
NCT06056310
Treatments Being Tested
Researchers will investigate the ability of Xevinapant to cross the blood-b...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-07-22
Trial ID
NCT06463184
Treatments Being Tested
The purpose of this study is to demonstrate the superior efficacy of Xevina...
Status
Terminated
Location
University of Alabama at Birmingham - Dept of Radiation Oncology
Start Date
2022-10-06
Trial ID
NCT05386550
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetics (PK) of Xevi...
Status
Completed
Location
Labcorp Clinical Research Unit Limited
Start Date
2022-09-26
Trial ID
NCT05519540
Treatments Being Tested
This phase II trial compares the effect of usual radiation therapy with cis...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-12
Trial ID
NCT06084845
The purpose of the study is to determine absorption, metabolism, and excret...
Status
Completed
Location
Labcorp Clinical Research Unit
Start Date
2021-08-02
Trial ID
NCT04962724
The primary objective of the study was to demonstrate superior efficacy of ...
Status
Terminated
Location
The University of Alabama at Birmingham - Hazelrig-Salter Radiation Oncology Center (HSROC)
Start Date
2020-08-07
Trial ID
NCT04459715
Treatments Being Tested
The purpose of this study is to test whether treatment with Xevinapant adde...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge
Start Date
2023-11-16
Trial ID
NCT06145412
Treatments Being Tested
Xevinapant is an antagonist of inhibitor of apoptosis proteins (IAPs) that ...
Status
Terminated
Location
Hôpital Nord Franche Compté
Start Date
2023-12-12
Trial ID
NCT05930938
Treatments Being Tested
This is a multicenter, randomized, placebo-controlled, triple blind, phase ...
Status
Terminated
Location
Onze Lieve Vrouw Ziekenhuis
Start Date
2023-11-15
Trial ID
NCT05724602
Treatments Being Tested